Summary of Consolidated Financial Results for Second Quarter (Interim Period) Fiscal Year 2026 (Under IFRS) 11/2 13:30TDnetPDF(477KB)
Notice Concerning Share of Profit of Investments Accounted for Using the Equity Method11/2 13:30TDnetPDF(105KB)
Sumitomo Chemical Announces Revisions to its Financial Forecast and Projected Dividend for the Full Year Ending March 31, 202711/2 13:30TDnetPDF(165KB)
当社グループに関するレポートについて(「Sumitomo Chemical and Sumitomo Pharmaceutical: The \116 Billion Swiss Shuffle」に関する追加説明)8/7 13:35TDnetPDF(371KB)
Notice Concerning Reduction of Capital Reserves and Transfer to Other Capital Surplus 8/3 15:30TDnetPDF(122KB)
(Progress of Disclosure Matters) Notice Concerning the Effectiveness of the Agreements for the Integration of the Domestic Polyolefin Business7/1 9:00TDnetPDF(128KB)
Notice Concerning Variances between the Non-consolidated Financial Results in a Consolidated Subsidiary (Taoka Chemical) for FY2025 and FY20245/15 15:00TDnetPDF(135KB)
Announcement of Reversal of Loss on a Write-down of Investment in Affiliates in Non-consolidated Financial Statements5/14 13:30TDnetPDF(134KB)